MultiQure S.A. (WSE:MQR)

Market Cap	345.40M +1,280.5%
Revenue (ttm)	n/a
Net Income	-154.00M
EPS	-16.15
Shares Out	225.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	109,502
Open	1.516
Previous Close	1.610
Day's Range	1.508 - 1.538
52-Week Range	1.290 - 6.650
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About MultiQure

MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFβ1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the αVβ8 integrin. The company was formerly known as Pure Biologics S.A. and changed its name to MultiQure S.A. in August 2026. The company was founded in 2010 and is based in Wroclaw, Poland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 7
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MQR

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 15, 2026

Data Sources Report a data error